Combinations for Treatment of NAFLD/NASH and Related Diseases

Combinations for Treatment of NAFLD/NASH and Related Diseases

A method for treating fatty liver disease and related diseases or disorders with a therapeutically effective amount of a composition comprising from about 25 mg to about 1200 mg of (S)-2-(5-((3-ethoxypyridin-2-yl)oxy)pyridin-3-yl)-N-(tetrahydrofuran-3-yl)pyrimidine-5-carboxamide or a pharmaceuticall...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Verhoest, Patrick Robert, Esler, William Paul, Pfefferkorn, Jeffrey Allen, Amin, Neeta Balkrishan, Calle, Roberto Arnaldo, Kim, Albert Myung, Bergman, Arthur James
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Verhoest, Patrick Robert
Esler, William Paul
Pfefferkorn, Jeffrey Allen
Amin, Neeta Balkrishan
Calle, Roberto Arnaldo
Kim, Albert Myung
Bergman, Arthur James
description A method for treating fatty liver disease and related diseases or disorders with a therapeutically effective amount of a composition comprising from about 25 mg to about 1200 mg of (S)-2-(5-((3-ethoxypyridin-2-yl)oxy)pyridin-3-yl)-N-(tetrahydrofuran-3-yl)pyrimidine-5-carboxamide or a pharmaceutically acceptable salt thereof, and from about 5 mg to about 40 mg of 4-(4-(1-Isopropyl-7-oxo-1,4,6,7-tetrahydrospiro[indazole-5,4′-piperidine]-1′-carbonyl)-6-methoxypyridin-2-yl)benzoic acid or a pharmaceutically acceptable salt thereof.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2023218616A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2023218616A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2023218616A13</originalsourceid><addsrcrecordid>eNrjZLB1zs9NysxLLMnMzytWSMsvUggpSk0syU3NK1HIT1Pwc3TzcdH3cwz2UEjMS1EISs1JLElNUXDJLE5NLE4t5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgZGxkaGFmaGZo6GxsSpAgAvfy-P</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Combinations for Treatment of NAFLD/NASH and Related Diseases</title><source>esp@cenet</source><creator>Verhoest, Patrick Robert ; Esler, William Paul ; Pfefferkorn, Jeffrey Allen ; Amin, Neeta Balkrishan ; Calle, Roberto Arnaldo ; Kim, Albert Myung ; Bergman, Arthur James</creator><creatorcontrib>Verhoest, Patrick Robert ; Esler, William Paul ; Pfefferkorn, Jeffrey Allen ; Amin, Neeta Balkrishan ; Calle, Roberto Arnaldo ; Kim, Albert Myung ; Bergman, Arthur James</creatorcontrib><description>A method for treating fatty liver disease and related diseases or disorders with a therapeutically effective amount of a composition comprising from about 25 mg to about 1200 mg of (S)-2-(5-((3-ethoxypyridin-2-yl)oxy)pyridin-3-yl)-N-(tetrahydrofuran-3-yl)pyrimidine-5-carboxamide or a pharmaceutically acceptable salt thereof, and from about 5 mg to about 40 mg of 4-(4-(1-Isopropyl-7-oxo-1,4,6,7-tetrahydrospiro[indazole-5,4′-piperidine]-1′-carbonyl)-6-methoxypyridin-2-yl)benzoic acid or a pharmaceutically acceptable salt thereof.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230713&amp;DB=EPODOC&amp;CC=US&amp;NR=2023218616A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230713&amp;DB=EPODOC&amp;CC=US&amp;NR=2023218616A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Verhoest, Patrick Robert</creatorcontrib><creatorcontrib>Esler, William Paul</creatorcontrib><creatorcontrib>Pfefferkorn, Jeffrey Allen</creatorcontrib><creatorcontrib>Amin, Neeta Balkrishan</creatorcontrib><creatorcontrib>Calle, Roberto Arnaldo</creatorcontrib><creatorcontrib>Kim, Albert Myung</creatorcontrib><creatorcontrib>Bergman, Arthur James</creatorcontrib><title>Combinations for Treatment of NAFLD/NASH and Related Diseases</title><description>A method for treating fatty liver disease and related diseases or disorders with a therapeutically effective amount of a composition comprising from about 25 mg to about 1200 mg of (S)-2-(5-((3-ethoxypyridin-2-yl)oxy)pyridin-3-yl)-N-(tetrahydrofuran-3-yl)pyrimidine-5-carboxamide or a pharmaceutically acceptable salt thereof, and from about 5 mg to about 40 mg of 4-(4-(1-Isopropyl-7-oxo-1,4,6,7-tetrahydrospiro[indazole-5,4′-piperidine]-1′-carbonyl)-6-methoxypyridin-2-yl)benzoic acid or a pharmaceutically acceptable salt thereof.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB1zs9NysxLLMnMzytWSMsvUggpSk0syU3NK1HIT1Pwc3TzcdH3cwz2UEjMS1EISs1JLElNUXDJLE5NLE4t5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgZGxkaGFmaGZo6GxsSpAgAvfy-P</recordid><startdate>20230713</startdate><enddate>20230713</enddate><creator>Verhoest, Patrick Robert</creator><creator>Esler, William Paul</creator><creator>Pfefferkorn, Jeffrey Allen</creator><creator>Amin, Neeta Balkrishan</creator><creator>Calle, Roberto Arnaldo</creator><creator>Kim, Albert Myung</creator><creator>Bergman, Arthur James</creator><scope>EVB</scope></search><sort><creationdate>20230713</creationdate><title>Combinations for Treatment of NAFLD/NASH and Related Diseases</title><author>Verhoest, Patrick Robert ; Esler, William Paul ; Pfefferkorn, Jeffrey Allen ; Amin, Neeta Balkrishan ; Calle, Roberto Arnaldo ; Kim, Albert Myung ; Bergman, Arthur James</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2023218616A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Verhoest, Patrick Robert</creatorcontrib><creatorcontrib>Esler, William Paul</creatorcontrib><creatorcontrib>Pfefferkorn, Jeffrey Allen</creatorcontrib><creatorcontrib>Amin, Neeta Balkrishan</creatorcontrib><creatorcontrib>Calle, Roberto Arnaldo</creatorcontrib><creatorcontrib>Kim, Albert Myung</creatorcontrib><creatorcontrib>Bergman, Arthur James</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Verhoest, Patrick Robert</au><au>Esler, William Paul</au><au>Pfefferkorn, Jeffrey Allen</au><au>Amin, Neeta Balkrishan</au><au>Calle, Roberto Arnaldo</au><au>Kim, Albert Myung</au><au>Bergman, Arthur James</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Combinations for Treatment of NAFLD/NASH and Related Diseases</title><date>2023-07-13</date><risdate>2023</risdate><abstract>A method for treating fatty liver disease and related diseases or disorders with a therapeutically effective amount of a composition comprising from about 25 mg to about 1200 mg of (S)-2-(5-((3-ethoxypyridin-2-yl)oxy)pyridin-3-yl)-N-(tetrahydrofuran-3-yl)pyrimidine-5-carboxamide or a pharmaceutically acceptable salt thereof, and from about 5 mg to about 40 mg of 4-(4-(1-Isopropyl-7-oxo-1,4,6,7-tetrahydrospiro[indazole-5,4′-piperidine]-1′-carbonyl)-6-methoxypyridin-2-yl)benzoic acid or a pharmaceutically acceptable salt thereof.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2023218616A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Combinations for Treatment of NAFLD/NASH and Related Diseases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T06%3A42%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Verhoest,%20Patrick%20Robert&rft.date=2023-07-13&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2023218616A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true